Monitored source Updated every 6h
PharmaTimes
PharmaTimes is an industry-news source covering pharma biotech that ScopePlex monitors daily for construction-phase signals. 1 public signals tracked.
PharmaTimes has contributed 1 public, confidence-scored construction signals tracked by ScopePlex. As an industry-news source, it surfaces pharma biotech construction activity — awards, financings, and groundbreakings — that ScopePlex cross-checks against primary records before a signal is published. For BD teams at specialty contractors, watching this source is one input into knowing which pharma biotech projects are entering the window where subcontract relationships are won — before the formal RFP.
Signals tracked
1
Class
industry news
Type
rss
Related sources in Pharmaceutical & Biotech
Recent public signals from this source
Gated intelligence
The facts are public. The intelligence is behind signup.
- Confidence score on every signal
- "Why it matters" — the BD read on each move
- Timing window & who to call
- Your curated daily brief, filtered to your sectors
- Saved pursuits, company watchlists & alerts
Unlock PharmaTimes intelligence →7-day trial · no card required